Skip to main content
HR 4229 109th Congress House Health Administrative procedure Contraceptives Department of Health and Human Services Drug approvals Food and Drug Administration (FDA) Government Operations and Politics Law

Plan B for Plan B Act of 2005

Introduced: November 3, 2005 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 17, 2006
Referred to the Subcommittee on Health.
Nov 3, 2005
Referred to the House Committee on Energy and Commerce.
Nov 3, 2005
Introduced in House
 Plain-English summary Congressional Research Service

Plan B for Plan B Act of 2005 - Requires the Commissioner of Food and Drugs to approve or disapprove within 30 days the supplemental new drug application submitted by Women's Capital Corporation for Plan B (defined as .75 mg levonorgestrel tablets [commonly referred to as the morning-after pill]), as amended by a formal response to the Food and Drug Administration's non-approvable determination, that would switch the drug from prescription-only to nonprescription status for women 16 years or older. Deems the Commissioner as having approved the application if the deadline is not met and continues such approval unless the Commissioner publishes in the Federal Register a determination to approve or disapprove the application.

What's happening now February 17, 2006

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2